All News
Should Pharmaceutical Companies Sell Weight-Loss Drugs Directly to Consumers?
(MedPage Today) -- This story is part of a series called "Ozempic: Weighing the Risks and Benefits." It was produced in part through a grant from the NIHCM Foundation.
Read MoreJAK Inhibitor Comes Up Short in Phase III Crohn's Disease Trial
(MedPage Today) -- An investigational oral Janus kinase (JAK) inhibitor failed to meet most primary endpoints in a phase III trial of patients with moderate to severe Crohn's disease, but the failure
Read MoreSelf-Pay, AI-Enhanced Breast Cancer Screening Detected More Cancers
(MedPage Today) -- Women who chose to enroll in a self-pay, artificial intelligence (AI)-enhanced breast cancer screening program were more likely to have cancer detected, researchers reported.
Read MoreAnthem Blue Cross Blue Shield Reverses Decision to Put a Time Limit on Anesthesia
(MedPage Today) -- One of the country's largest health insurers reversed a change in policy Thursday after widespread outcry, saying it would not tie payments in some states to the length of time a p
Read MoreFostamatinib Fails to Improve Outcomes in Hypoxemic COVID Patients
(MedPage Today) -- The spleen tyrosine kinase inhibitor fostamatinib (Tavalisse) did not improve outcomes in adults hospitalized with COVID-19 and hypoxemia, according to a phase III trial published
Read MorePor qué el sarampión, la tos ferina y otras enfermedades graves podrían resurgir con RFK Jr.
Expertos afirman que una confluencia de factores podría causar el resurgimiento de epidemias mortales de enfermedades como el sarampión, la tos ferina y la meningitis, o incluso de polio.
Read MoreAddicted to Productivity, Doc? The Holidays Are a Time to Reflect
(MedPage Today) -- As physicians, we are too familiar with the toll work and productivity take on our health.
Read MoreTheir marriage and scientific synergy resulted in a Nobel Prize — for him
I saw the “Wicked” movie last week and haven’t been able to stop thinking about it.
Read MoreSTAT+: Pharmalittle: We’re reading about cracks in the MAHA alliance, pharmacies suing GoodRx and PBMs, and more
The diverse alliance that makes up the MAHA movement is showing some cracks over Trump's picks to lead health-related agencies
Read MoreNew Clues in CEO's Killing; Time to Worry About Disease X? Ketamine Diversions Grow
(MedPage Today) -- Note that some links may require registration or subscription.
Read More